Breaking News

PAREXEL, Lilly in Asia/Pac Pact

Lilly to outsource start-up and monitoring for Asia/Pac trials

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PAREXEL International and Eli Lilly and Co. have established a strategic functional service provider relationship to support study start-up and site monitoring of clinical trials throughout the Asia/Pacific region. PAREXEL will assist Lilly in bringing greater efficiencies to its clinical research studies to help meet Lilly’s development and commercialization goals. Lilly will access PAREXEL’s talent and experience in Asia and Australia for study start-up and site monitoring. The collaboratio...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters